ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

Last updated:

AskBio - About the company

AskBio is an acquired company based in Durham (United States), founded in 2001 by and . It operates as a Provider of gene and protein therapies to treat various diseases. AskBio has raised $235M in funding from TPG and Vida Ventures. The company has 717 active competitors, including 266 funded and 157 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Recursion and Spark Therapeutics.

Company Details

Provider of gene and protein therapies to treat various diseases. The company is engaged in the development and delivery of novel protein and cellular-based therapies through the design of proprietary recombinant Adeno associated virus (AAV) Biological Nano Particles (BNP). The gene delivery technology platform provides unsurpassed transduction efficiency, "ramp-up" expression capabilities, with tissue targeting and de-targeting properties. Its product pipeline includes drugs to treat muscular dystrophy, hemophilia B (Phase 1), congestive heart failure, epilepsy, retinitis pigmentosa, and osteoporosis.
Website
Social
Phone Number
+1
Key Metrics
Founded Year
2001
Location
Durham, United States
Stage
Acquired
Total Funding
in 5 rounds
Latest Funding Round
Investors
Ranked
Similar Companies
Exit Details
Acquired by Bayer (Oct 26, 2020)

Legal entities associated with AskBio

AskBio is associated with 1 legal entity given below:
Legal Entity Name
Date of incorporation
Revenue
Net Profit
Employee Count
$1M - $5M (as on May 15, 2018)
377
434
Get your free copy of AskBio's company profile

AskBio's acquisition details

AskBio got acquired by Bayer on Oct 26, 2020 at an acquisition amount of $2B. It was facilitated by J P Morgan, Ropes & Gray and Credit Suisse.
Click to take a look at AskBio's acquisition in detail

AskBio's funding and investors

AskBio has raised a total funding of $235M over 5 rounds. Its first funding round was on Sep 30, 2008. Its latest funding round was a Grant (prize money) round on Sep 02, 2020 for $2.68M. 1 investor participated in its latest round, which include TPG, Golden Valley Capital, HHS and .

AskBio has 6 institutional investors including TPG, Vida Ventures and .

Here is the list of recent funding rounds of AskBio:
Date of funding
Funding Amount
Round Name
Post money valuation
Revenue multiple
Investors
Sep 02, 2020
$2.68M
Grant (prize money)
1878256
3436376
Apr 11, 2019
$235M
PE
2602321
9998274
Aug 15, 2014
$270K
Grant (prize money)
7542685
9601656
lockAccess funding benchmarks and valuations. Sign up today!

AskBio's founders and board of directors

The founders of AskBio are and . is the CEO of AskBio.

AskBio's Competitors and alternates

Top competitors of AskBio include Jazz Pharmaceuticals, Recursion and Spark Therapeutics. Here is the list of Top 10 competitors of AskBio, ranked by ÃØÃÜÑо¿Ëù score :
Overall Rank
Company Details
Short Description
Total Funding
Investors
ÃØÃÜÑо¿Ëù Score
1st
Logo for Jazz Pharmaceuticals
Jazz Pharmaceuticals
2003, Dublin (Ireland), Public
Developer of therapeutics for cancer and neurological disorders
$265M
85/100
2nd
R&D based company focused on manufacturing of drugs for multiple therapeutic areas
$452M
HTIF, Menlo VenturesÌý&²¹³¾±è;Ìý
81/100
3rd
Logo for Spark Therapeutics
Spark Therapeutics
2013, Philadelphia (United States), Acquired
Developer of gene therapy for rare diseases
$82.8M
Sofinnova Investments, DeerfieldÌý&²¹³¾±è;Ìý
80/100
4th
Logo for Amyris
Amyris
2003, Emeryville (United States), Public
Developer of renewable products for industrial solutions
$487M
Hercules Capital, TPGÌý&²¹³¾±è;Ìý
79/100
5th
Logo for Biogen
Biogen
1978, Cambridge (United States), Public
Developer of therapies for neurodegenerative and immunology disorders
$80M
78/100
6th
Logo for Neurocrine
Neurocrine
1992, San Diego (United States), Public
Developer of small molecule therapeutics for endocrine and CNS disorders
$10M
Venrock, HBM Healthcare InvestmentsÌý&²¹³¾±è;Ìý
74/100
7th
Logo for PTC Therapeutics
PTC Therapeutics
1998, South Plainfield (United States), Public
Developer of small molecule drugs for the treatment of rare diseases
$248M
74/100
8th
Logo for Syngenta
Syngenta
2000, Basel (Switzerland), Acquired
Provider of crop inputs for farming
-
74/100
9th
Logo for Biohaven Pharmaceutical
Biohaven Pharmaceutical
2014, New Haven (United States), Acquired
Developer of therapies targeting neurological and neuropsychiatric diseases
$84.1M
Aisling Capital, VenrockÌý&²¹³¾±è;Ìý
73/100
10th
Logo for AskBio
2001, Durham (United States), Acquired
Provider of gene and protein therapies to treat various diseases
$235M
TPG, Golden Valley CapitalÌý&²¹³¾±è;Ìý
65/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on AskBio's competitors? Click to see the top ones

AskBio's Investments and acquisitions

AskBio has made no investments or acquisitions yet.

Reports related to AskBio

Here is the latest report on AskBio's sector:
View

News related to AskBio

Media has covered AskBio for a total of 10 events in the last 1 year, 4 of them have been about company updates and 2 about partnerships.
•
GlobeNewswire•Mar 07, 2025•AskBio
•
GlobeNewswire•Feb 19, 2025•AskBio
•
GlobeNewswire•Feb 13, 2025•AskBio
•
GlobeNewswire•Jan 14, 2025•AskBio
•
Financial Post•Nov 07, 2024•AskBio
•
Pharmaceutical Technology•Sep 26, 2024•AskBio, BBM
•
PR Newswire•Sep 25, 2024•BBM, AskBio
•
GlobeNewswire•Jul 11, 2024•AskBio
•
Clinical Trials Arena•Jun 26, 2024•AskBio
•
GlobeNewswire•Apr 18, 2024•AskBio
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

Frequently asked questions about AskBio

When was AskBio founded?
AskBio was founded in 2001.
Where is AskBio located?
AskBio is located in Durham, United States.
Is AskBio an acquired company?
AskBio got acquired by Bayer on Oct 26, 2020.
When was the latest funding round of AskBio?
AskBio's latest funding round was on Sep 02, 2020.
What is the annual revenue of AskBio?
Annual revenue of AskBio is undefined as on undefined.
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
  • check icon 4M+ Companies
  • check icon 212K+ Investors
  • check icon 580K+ Funding Rounds
  • check icon 207K+ Acquisitions
  • check icon 2.9K+ Sectors
  • check icon 57K+ Business Models

Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford
Are you a Founder ?
Explore our recently published companies
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long